Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors for Treatment of High Cholesterol Levels: Effectiveness and Value

JAMA Internal Medicine (2016) - Comments
pubmed: 26662572 doi: 10.1001/jamainternmed.2015.7248 issn: 2168-6114 issn: 2168-6106

Jeffrey A. Tice, Dhruv S. Kazi, Steven D. Pearson